Axogen Inc vs Allbirds Inc — how do they compare? Axogen Inc trades at $38.69 (market cap $2.06B), while Allbirds Inc trades at $2.9 (market cap $25.89M). The key difference: Axogen Inc is far larger — about 79.6× Allbirds Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | BIRD | |
|---|---|---|
Market Cap | $2.06B | $25.89M |
Sector | Technology | Consumer Cyclical |
52-Week High | $46.19 | $16.99 |
52-Week Low | $11.28 | $2.39 |
Enterprise Value | $1.98B | $44.76M |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →